Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap

Integrating context-appropriate molecular diagnostics into LMIC cancer programs is essential to reduce inequities.

Saved in:
Bibliographic Details
Published inJCO global oncology Vol. 8; no. 8; p. e2200182
Main Authors Erfani, Parsa, Bates, Michael, Garcia-Gonzalez, Pat, Milner, Dan A, Rebbeck, Timothy R, Ruhangaza, Deogratias, Shulman, Lawrence N, Fadelu, Temidayo
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health 01.10.2022
American Society of Clinical Oncology
Subjects
COMMENTARIES
Humans
Neoplasms - diagnosis
Neoplasms - therapy
Pathology, Molecular
Technology
Online AccessGet full text

Cover

More Information
Summary:Integrating context-appropriate molecular diagnostics into LMIC cancer programs is essential to reduce inequities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2687-8941
2687-8941
DOI:10.1200/GO.22.00182